Balyasny Asset Management’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-22,246
| Closed | -$309K | – | 2161 |
|
|
2024
Q1 | $309K | Buy |
+22,246
| New | +$309K | ﹤0.01% | 1648 |
|
|
2023
Q4 | – | Sell |
-1,524
| Closed | -$7.11K | – | 2087 |
|
|
2023
Q3 | $7.11K | Sell |
1,524
-5,662
| -79% | -$26.4K | ﹤0.01% | 1705 |
|
|
2023
Q2 | $38.5K | Buy |
+7,186
| New | +$38.5K | ﹤0.01% | 1740 |
|
|
2023
Q1 | – | Sell |
-4,055
| Closed | -$75.9K | – | 2411 |
|
|
2022
Q4 | $75.9K | Sell |
4,055
-1,389
| -26% | -$26K | ﹤0.01% | 1845 |
|
|
2022
Q3 | $113K | Buy |
5,444
+737
| +16% | +$15.3K | ﹤0.01% | 1910 |
|
|
2022
Q2 | $98K | Buy |
+4,707
| New | +$98K | ﹤0.01% | 1836 |
|
|
2020
Q2 | – | Sell |
-27,791
| Closed | -$2.48M | – | 1134 |
|
|
2020
Q1 | $2.48M | Buy |
+27,791
| New | +$2.48M | 0.03% | 488 |
|
|
2016
Q1 | – | Sell |
-2,992
| Closed | -$241K | – | 1175 |
|
|
2015
Q4 | $241K | Buy |
+2,992
| New | +$241K | ﹤0.01% | 906 |
|